Vimarsana
Biggest News Aggregation in the World

Page 2 - Nasdaq Vxrt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Vxrt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Vxrt Today - Breaking & Trending Today

Vaxart Encourages All Stockholders of Record as of April - Vimarsana News

Vaxart Encourages All Stockholders of Record as of April

SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today encourages its stockholders of record on April 28, 2023,...

Vaxart, Inc. Announces Pricing of $15,000,000 Public - Vimarsana News

Vaxart, Inc. Announces Pricing of $15,000,000 Public

SOUTH SAN FRANCISCO, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced the pricing of its underwritten public...

Vaxart (NASDAQ:VXRT) Shares Cross Below 200 Day Moving Average of $1.02 - Vimarsana News

Vaxart (NASDAQ:VXRT) Shares Cross Below 200 Day Moving Average of $1.02

Vaxart, Inc. (NASDAQ:VXRT – Get Rating)’s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.02 and traded as low as $0.85. Vaxart shares last traded at $0.86, with a volume of 512,683 shares traded. Vaxart Price Performance The firm has a market […]

Source: wkrb13.com
Financial Survey: Vaxart (NASDAQ:VXRT) and 4D Molecular Therapeutics (NASDAQ:FDMT) - Vimarsana News

Financial Survey: Vaxart (NASDAQ:VXRT) and 4D Molecular Therapeutics (NASDAQ:FDMT)

Vaxart (NASDAQ:VXRT – Get Rating) and 4D Molecular Therapeutics (NASDAQ:FDMT – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings. Risk and Volatility Vaxart has a beta of 0.82, […]

Vaxart Announces Collaborative Funding from Leading - Vimarsana News

Vaxart Announces Collaborative Funding from Leading

Funding and support provided by Bill & Melinda Gates Foundation Study will focus on determining the ability of oral vaccine tablets to induce breast...